Mydayda Inc.

Mydayda Inc. is a healthcare technology company based in the US, specializing in Custom Chronic Care Management (CCM) and Remote Patient Monitoring (RPM) solutions to enhance patient engagement and streamline healthcare delivery. Founded in 2015 and headquartered in Sacramento, California, Mydayda Inc. focuses on advancing chronic care management through digital health solutions.

The company's CEO, Jose Torres, has a background in healthcare technology, contributing to its innovative approaches. Mydayda has successfully engaged in one funding deal, raising an undisclosed amount from investor Reform Ventures, indicating interest in expanding its market presence. Mydayda's primary offerings include Custom Chronic Care Management (CCM) and Remote Patient Monitoring (RPM) solutions, designed to enhance healthcare delivery outside traditional office visits. These digital platforms facilitate real-time health data sharing between patients and clinical teams, thereby streamlining chronic care management and improving patient outcomes.

The Mydayda App allows users to connect with Bluetooth-enabled devices, capturing and transmitting encrypted health data directly into electronic medical records (EMRs) for instant access by healthcare providers. Mydayda caters to a diverse client base, including clinicians and healthcare organizations, particularly in markets such as the United States, where both Medicare and private payer reimbursement models support the integration of telehealth services into clinical practice. The solutions are tailored to accommodate numerous use cases, enabling healthcare providers to optimize their patient engagement efforts and operational efficiency. Mydayda generates revenue primarily through its CCM and RPM services, which operate on a subscription-based model tailored for both B2B and direct-to-consumer transactions.

Clinicians and healthcare organizations pay monthly fees based on the number of patients utilizing the platform, with an emphasis on scalable solutions that can integrate seamlessly into existing workflows. For instance, revenue from RPM services involves a structure where healthcare providers receive reimbursement from private payers, while CCM services often rely on Medicare reimbursement. The average time spent by patients on these services is quantified, with data showing potential for substantial monthly revenues associated with both RPM and CCM offerings. This structured approach allows Mydayda to maintain a steady revenue stream while positioning itself as a critical player in the telehealth landscape.

Mydayda Inc. plans to utilize its recent funding from Reform Ventures to support the development of new products in the CCM and RPM domains, enhancing their platform's capabilities. The company aims to expand into additional geographic regions across North America by the end of 2024, further increasing access to their services. This strategy, combined with ongoing product enhancements, is expected to bolster Mydayda's market presence and improve healthcare delivery outcomes.